Skip to main content

$0.125 (0%)

High

$0.13

Low

$0.12

Trades

20

Turnover

$48,049

Volume

400,697
30 June 2023 at 3:57pm
Register to track CYP and receive email alerts.
Subject
CYP Ann: Cynata to Present at MST Access Investor Conference 15 June

CYP Ann: Cynata signs Licence Agreement with TekCyte

CYP Ann: Release of Securities from Voluntary Escrow

CYP Ann: First Patient Enrolled in Cynata MEND Clinical Trial

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cynata Expands trial in COVID-19 & Respiratory Failure

CYP Ann: Cynata Investor Presentation

CYP Ann: New Study to Investigate the High Potency of Cymerus MSCs

CYP Ann: Cynata Advances Planned Clinical Trial in DFU with TekCyte

CYP Ann: Appendix 4D & Half-Year Financial Statements

CYP Ann: Cynata Receives $1.39m R&D Tax Incentive Refund

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: Completion of Entitlement Offer and Shortfall Placement

CYP Ann: Entitlement Offer Closing Date Reminder

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: 2020 Review and Outlook

CYP Ann: Becoming a substantial holder

CYP Ann: Cleansing Notice

CYP Ann: Appendix 2A

CYP Ann: Letter to Ineligible Shareholders

CYP Ann: Offer Booklet and Entitlement & Acceptance Form

CYP Ann: Cynata Entitlement Offer Opens

CYP Ann: Cleansing Notice

CYP Ann: Cynata provides update on Placement and Appendix 2A

CYP Ann: Letter to Optionholders

CYP Ann: Notice Under Section 708AA of the Corporations Act

CYP Ann: Investor Presentation

CYP Ann: Proposed issue of Securities - CYP

CYP Ann: CYP Closes $15m Institutional Placement to Expand Pipeline

CYP Ann: Trading Halt

CYP Ann: Appendix 3Ys x 5

CYP Ann: Appendix 3G

CYP Ann: Replacement Constitution

CYP Ann: Results of Annual General Meeting

CYP Ann: AGM Presentations

CYP Ann: Cynata Technology Featured on Front Cover of Nature Medicine

CYP Ann: Phase 3 Osteoarthritis Clinical Trial Commences

CYP Ann: Quarterly Activity Report & Appendix 4C

CYP Ann: AusBiotech Conference Presentation

CYP Ann: Annual Report to Shareholders

CYP Ann: Letter to Shareholders, Notice of AGM & Proxy Form

CYP Article: 'It had the smell of Lehman Brothers'

CYP Article: Alium ups stake in Emerald Clinics in upcoming IPO

CYP Article: The interview questions these 28 Australian CEOs always ask ...

CYP Article: Markets Live: Financials plummet on euro concerns

Register to track CYP and receive email alerts.

Similar Companies

CSL ...
CSL
CUV
IMM
IMU
MSB
OPT
PAR
PYC
RAC
TLX